
21 Atorvastatin (S24E21)
Nearly 45% of all deaths from non-communicable diseases worldwide are caused by cardiovascular disease—a staggering reality that frames the story of atorvastatin, better known as Lipitor. In this episode of From Concept

Loading…

Hosted by Jim Mitchell · 🇺🇸 US · EN · 270 episodes
Established thought leaders with verified media credentials.
Welcome to a Complete Drug Development Journey! Have you ever wondered how groundbreaking medicines go from a scientist’s vision to life-saving treatments in hospitals and pharmacies worldwide? The journey of drug development is an intricate, high-stakes adventure—filled with scientific breakthroughs, regulatory twists, and the relentless pursuit of innovation. In this podcast, we take you behind the scenes of pharmaceutical research and development, unraveling the complex and fascinating process that transforms a promising compound into a fully approved, market-ready medicine. Each episode is a deep dive into the critical stages of drug development, including: 🔬 Drug Discovery: Where innovation begins—exploring cutting-edge research, target identification, and the quest for the next medical breakthrough. 🧪 Preclinical Testing: Investigating safety, efficacy, and mechanisms of action before a drug ever reaches human trials. 👩⚕️ Cl
Jim Mitchell hosts From Concept to Medicine - A Comprehensive Drug Development Journey, a science show with 270 episodes published.

Nearly 45% of all deaths from non-communicable diseases worldwide are caused by cardiovascular disease—a staggering reality that frames the story of atorvastatin, better known as Lipitor. In this episode of From Concept

In this compelling Deep Dive, we explore the unglamorous but absolutely essential world of medical device documentation. From design inception to post-market surveillance, documentation isn't just red tape—it's the backb

In this expansive episode of The Deep Dive, we explore the full lifecycle of liraglutide, a first-generation GLP-1 receptor agonist that helped redefine how we treat both type 2 diabetes and obesity. From the early 20th-

In this compelling episode of The Deep Dive, we explore the multifaceted story of pioglitazone, a thiazolidinedione (TZD) insulin sensitizer used to treat type 2 diabetes. From its origins in 1980s Japan to its developme

In this episode of The Deep Dive, we explore the full lifecycle of sitagliptin, the first oral DPP-4 inhibitor to revolutionize type 2 diabetes management. Starting with its scientific origins in the 1990s, the episode t

In this episode of The Deep Dive, we explore the remarkable journey of exenatide, a diabetes medication that began in an unlikely place—Gila monster saliva. As the first GLP-1 receptor agonist approved for type 2 diabete

In this in-depth episode of From Concept to Medicine, we take a comprehensive look at glipizide, a widely used second-generation sulfonylurea for type 2 diabetes. The episode begins with a historical overview of the sulf

In this deep dive, we explore the foundation of U.S. medical device quality regulation: the FDA’s Quality System Regulation, also known as 21 CFR Part 820. Framed as more than just paperwork, the QSR is revealed to be th

This episode explores the FDA’s regulatory pathways for medical device clearance and approval, peeling back the layers of risk-based classification and submission strategies. From simple class I devices like elastic band

In this comprehensive deep dive, we journey through the entire lifecycle of a medical device—from that first spark of an idea to post-market surveillance. The episode unpacks the structured and often invisible process th

In this epic exploration, we trace the astonishing story of insulin, a life-saving hormone that reshaped modern medicine—and human destiny. From its biological roots in ancient evolutionary systems (even cone snails use

In this sweeping exploration of Metformin, we uncover the remarkable transformation of a medieval herbal remedy into one of the world’s most essential medicines for managing type 2 diabetes. Originating from Galega offic

Clindamycin may not be the flashiest antibiotic on the shelf, but its journey from a chlorinated cousin of lincomycin to a crucial treatment for bone infections, surgical prophylaxis, and penicillin-allergic patients tel

In this Deep Dive, we unravel the intricate story of Levofloxacin, a third-generation fluoroquinolone antibiotic with a sweeping medical profile and a regulatory history to match. Originally patented in 1987 and approved

Ciprofloxacin—once hailed as a miracle of modern medicine—takes center stage in this expansive episode of The Deep Dive. We trace its journey from its roots in the quinolone family to its transformation into a potent flu

In this foundational episode, we explore how medical devices are defined and classified by the FDA—a critical first step in navigating the regulatory landscape. Starting with the legal distinction between devices and dru

Azithromycin may be the most recognizable “Z-Pak” in the pharmacy, but its journey from Eastern European innovation to global blockbuster is anything but ordinary. This episode follows its origins as a chemical upgrade t

Erythromycin has been punching above its weight for decades. In this episode, we chart its rise from a soil-derived discovery by Saccharopolyspora erythraea to its position as a foundational macrolide antibiotic. Known f

Amoxicillin is everywhere—from pediatricians’ offices to disaster relief kits—and for good reason. In this episode, we dive into its 1970s debut as a more bioavailable cousin to ampicillin, crafted by Beecham Laboratorie

Few drugs have reshaped the world like penicillin. In this episode, we trace its origin story—from Alexander Fleming’s serendipitous discovery in 1928 to the urgent push during World War II that turned moldy lab dishes i
Sponsor detection runs nightly. Check back soon.
No public pitch examples yet for this show.
Generate your own personalised pitchBased on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.







From Concept to Medicine - A Comprehensive Drug Development Journey has a verified contact on file. Create a free PitchCentric account to access it and generate a personalised pitch in seconds. Research at least 3 recent episodes first and lead with a specific angle that serves their science audience.
From Concept to Medicine - A Comprehensive Drug Development Journey is hosted by Jim Mitchell. The show is categorised under science (chemistry) and has published 270 episodes.
From Concept to Medicine - A Comprehensive Drug Development Journey has published 270 episodes.
From Concept to Medicine - A Comprehensive Drug Development Journey regularly covers science, chemistry, education. It sits in the science category, with a chemistry focus.
From Concept to Medicine - A Comprehensive Drug Development Journey is accessible for guests with genuine science expertise. A personalised, episode-aware pitch will still outperform a generic one every time.
From Concept to Medicine - A Comprehensive Drug Development Journey hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.
Episodes of From Concept to Medicine - A Comprehensive Drug Development Journey average 22 minutes. a focused format where a clear narrative arc and tight preparation matter most.
Our data rates From Concept to Medicine - A Comprehensive Drug Development Journey's guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.
Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched 4 days ago.